MR spectroscopy

Related by string. MR Spectroscopy * MS RD . MRS . mr . MRD . mrs . MRED . Mr. : Mr de Menezes . Mr Downer . Mr. Potato Head . Mr Salmond . Mrs Gandhi . Mr Straw . Mrs McCann / Spectroscopy : atomic absorption spectroscopy . Raman spectroscopy . magnetic resonance NMR spectroscopy . Raman Spectroscopy . fluorescence spectroscopy . correlation spectroscopy . NMR spectroscopy * proton MR spectroscopy *

Related by context. All words. (Click for frequent words.) 68 immunohistochemical analysis 68 F FDG PET 68 Doppler echocardiography 68 transabdominal 67 #F FDG PET 67 semiquantitative 67 Immunohistochemical staining 66 scintigraphic 66 HER2 expression 66 pelvic ultrasound 66 gadolinium enhanced 66 #F FDG 66 thyroglobulin 66 bone scintigraphy 66 cardiac magnetic resonance 65 scintigraphy 65 FDG-PET/CT 65 T1 weighted 65 immunohistochemical 65 histopathological 65 Magnetic resonance 65 fluorescein angiography 65 DCE MRI 65 FDG PET imaging 65 FDG uptake 65 clinicopathological 64 transvaginal sonography 64 immunohistochemical staining 64 urine cytology 64 immunostaining 64 perfusion imaging 64 biochemical abnormalities 64 FDG PET scans 64 fundus photography 64 angiographically 64 Preoperative 64 core needle biopsies 64 tracer uptake 64 Histologic 64 Diffusion weighted 64 hematological relapse 64 MR imaging 64 Histological 64 stratifying patients 64 murine model 64 transcranial Doppler 64 apparent diffusion coefficient 64 hamartomas 64 cardiac perfusion 63 transient elastography 63 arthrography 63 TRUS 63 Kruskal Wallis test 63 metabolite concentrations 63 FDG PET 63 diffusion tensor 63 prognostic significance 63 prostate carcinoma 63 mCi 63 immunoblotting 63 nodal metastasis 63 diffusion weighted 63 micrometastasis 63 Computed tomography 63 troponins 63 B7 H3 63 multivariable analysis 63 pathologic diagnosis 63 multivariate analyzes 63 Ultrasonographic 63 Multivariate analysis 63 computed tomographic 63 fluorodeoxyglucose 62 transesophageal echocardiography 62 F FDG 62 histopathologic findings 62 tomography scans 62 ECG gated 62 noninvasive imaging 62 F FDG uptake 62 transrectal ultrasound guided 62 multiple logistic regression 62 proton MR spectroscopy 62 adnexal mass 62 proton magnetic resonance 62 electrophysiologic 62 serum cortisol 62 ultrasonographic 62 florbetaben 62 endoscopic ultrasonography 62 TRUS biopsy 62 chest radiographs 62 RRM1 62 histopathologic examination 62 computed tomography scan 62 histologic findings 62 morphometry 62 Western blotting 62 spiral computed tomography 62 thermogram 62 bronchoalveolar lavage 62 PET CT scans 62 mammographic density 62 T2 weighted images 62 Confocal microscopy 62 histopathologic 62 positron emission tomography scans 62 FDG PET CT 62 hepatic lesions 62 intraobserver 62 transthoracic 62 Univariate analysis 62 extramedullary 62 logistic regression analyzes 62 arteriography 62 nomograms 61 CT angiography CTA 61 biopsy specimens 61 tumor subtypes 61 myocardial perfusion 61 tumor histology 61 helical CT 61 lung nodule 61 computerized tomography scan 61 conventional coronary angiography 61 Subgroup analysis 61 CT perfusion 61 proteomic analysis 61 dosimetric 61 EEG recordings 61 computed tomography SPECT 61 preoperative diagnosis 61 hamartoma 61 mucinous 61 radiotherapy RT 61 histologically proven 61 intact parathyroid hormone 61 cytologic 61 sonographic findings 61 endometrial biopsy 61 waist circumference WC 61 multivariate logistic regression 61 prognostic biomarker 61 transrectal ultrasound 61 pT2 61 coronary stenosis 61 Histopathological 61 tumor biopsies 61 #F fluorodeoxyglucose 61 Doppler sonography 61 ^ sup #m 61 echocardiographic 61 computed tomography scans 61 rCBF 61 mRNA expression 61 genetic polymorphisms 61 tumor hypoxia 61 sonographically guided 61 transthoracic echocardiography 61 histologic examination 61 anthropometric measurements 61 Lymph node 61 Ultrasonography 61 digital subtraction angiography 61 ERalpha 61 transcriptomic 61 computerized tomography scans 61 magnetic resonance spectroscopy 61 multislice 61 MR angiography 61 biochemical relapse 61 stress echocardiography 61 clinicopathological features 61 SELDI TOF MS 61 gene polymorphisms 61 electron beam computed tomography 61 flavopiridol 61 preoperative staging 61 artery stenosis 61 RQ PCR 61 colorectal adenoma 61 biochemical markers 61 positron emission 61 Doppler ultrasonography 61 ultrastructural 61 unresectable tumors 61 SPECT myocardial perfusion imaging 61 adrenalectomy 61 NMIBC 61 prognostic indicators 61 spirometric 61 conventional angiography 60 hematological parameters 60 immunoreactivity 60 CC genotype 60 pelvic lymphadenectomy 60 renal biopsy 60 surgically resected 60 cytological 60 biopsied tissue 60 colorectal adenocarcinoma 60 metaplasia 60 ABL1 60 duplex ultrasonography 60 PSA nadir 60 TIMP 1 60 Doppler ultrasound 60 multivariate Cox 60 histological subtype 60 excisional biopsy 60 tumorigenicity 60 DNA methylation markers 60 Positron emission tomography PET 60 immunoblot 60 AST ALT 60 microsatellite instability 60 DEXA scan 60 transcranial Doppler ultrasound 60 ventricular myocardium 60 EUS FNA 60 angiography CCTA 60 PiB PET 60 T2 weighted 60 aminotransferases 60 perioperative complications 60 fluorescence spectroscopy 60 cardiac troponin T 60 prostate cancer CaP 60 PET imaging 60 endorectal coil 60 miRNA expression 60 methacholine challenge 60 EBUS FNA 60 T1 weighted images 60 urothelial cancer 60 invasive carcinomas 60 TIMP 60 thyroid carcinoma 60 gastric carcinomas 60 genomewide 60 myo inositol 60 intracoronary 60 serum lipid 60 SPECT CT imaging 60 thyroid stimulating hormone 60 renal cell carcinomas 60 differential gene expression 60 Computed tomographic 60 metastatic lymph nodes 60 Multivariate logistic regression 60 Raman spectra 60 ductal carcinomas 60 microdissection 60 gene expression profiles 60 Immunohistochemical analysis 60 Single photon emission 60 sonographic examinations 60 chromosomal aberrations 60 Histopathologic 60 logistic regression model 60 bladder tumors 60 radiotracer 60 nodal metastases 60 hematopoietic cancers 60 mammographically 60 myocardial viability 60 powder diffraction 60 Clusterin 60 hepatic arterial 60 conditional logistic regression 60 genomic alterations 60 leiomyomas 60 univariate 60 aminotransferase 60 Functional magnetic resonance 60 interobserver 60 Multiple logistic regression 60 fine needle aspiration 60 computed tomographic scans 60 denervation 60 pulmonary angiography 60 MSCT 60 Microarray analysis 59 pleural fluid 59 alkaline phosphatase ALP 59 serum markers 59 echo planar 59 RT PCR assay 59 Immunohistochemical 59 radioimmunoassay 59 plain radiographs 59 urodynamic 59 transrectal ultrasonography 59 malignant nodules 59 pathologic examination 59 parathyroid 59 abdominal computed tomography 59 Electrophysiological 59 ductal adenocarcinoma 59 TMPRSS2 ERG 59 percutaneous biopsy 59 axillary dissection 59 lesional 59 Immunohistochemistry 59 interobserver agreement 59 adnexal masses 59 clinicopathologic 59 ANCOVA 59 N glycan 59 circular dichroism 59 inhibin B 59 PET tracer 59 preoperative evaluation 59 myocardial revascularization 59 cytokeratin 59 nodal dissection 59 myogenic 59 CSF biomarkers 59 Magnetic resonance imaging 59 papillary thyroid carcinoma 59 radiotracers 59 LHRH receptor positive 59 ALA PDT 59 #F FDG PET CT 59 cerebral angiography 59 Hurthle cell 59 CTEPH 59 SNP rs# [001] 59 Logistic regression 59 flow cytometric 59 APOE genotype 59 Univariate 59 optical coherence tomography 59 contrast echocardiography 59 neurosensory 59 carotid stenosis 59 fetal echocardiography 59 Fine needle aspiration 59 cTnI 59 differentially expressed genes 59 immunofluorescence microscopy 59 lymph node metastasis 59 radionuclide imaging 59 cardiac computed tomography 59 cisplatin resistant 59 densitometry 59 Prostate specific antigen 59 urothelial carcinoma 59 CT angiograms 59 bioluminescence imaging 59 needle aspiration 59 hypometabolism 59 Cystoscopy 59 morphologic 59 autoregulation 59 multiple linear regression 59 malignant prostate 59 enzyme inhibition 59 vastus lateralis 59 hMG 59 SLN biopsy 59 estrogen receptor ER 59 hyperintensity 59 Doppler imaging 59 NIR spectroscopy 59 prostate epithelial cells 59 Preoperatively 59 microvessel 59 histologic 59 laterality 59 spontaneous regression 59 vascular lesion 59 electroencephalographic 59 perfusion abnormalities 59 fluorodeoxyglucose positron emission tomography 59 striatal 59 gene polymorphism 59 transcranial 59 Scintigraphy 59 chromosomal mutations 59 CIN2 + 59 eNO 59 MDCT angiography 59 gene amplification 59 sensitivity specificity 59 induced sputum 59 C telopeptide 59 morphometric 59 ROC curves 59 paricalcitol 59 anti JCV antibodies 59 demyelinating 59 hyperintense lesions 59 perfusion CT 59 differentially expressed proteins 59 prostate cancer PCa 59 electrospray ionisation 59 diagnostically 59 Sonographic 59 methylation patterns 59 Positron emission tomography 59 radiation dosimetry 58 DNA methylation patterns 58 underwent coronary angiography 58 neuroimaging studies 58 NSCLC tumors 58 quantitative RT PCR 58 computed tomographic angiography 58 HCT# 58 muscle biopsies 58 Color Doppler 58 radiolabeled 58 computed tomographic scan 58 intima media thickness 58 BMS# 58 paraneoplastic 58 lactate dehydrogenase 58 endothelial activation 58 clefting 58 colorectal carcinoma 58 NPM1 mutation 58 dimensional echocardiography 58 immunohistochemistry IHC 58 fluoroscopy guided 58 PET tracers 58 ovarian malignancy 58 quantitative computed tomography 58 resonance imaging 58 sputum cytology 58 diabetes mellitus DM 58 liver biopsies 58 coronary CTA 58 multidetector CT 58 logistic regression analysis 58 stent stenosis 58 esophageal manometry 58 pulsed Doppler 58 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 58 methylation markers 58 rs# [004] 58 preoperatively 58 hepatocellular carcinomas 58 diagnostic modality 58 radiographic findings 58 interobserver reliability 58 tomography PET 58 Radiofrequency ablation 58 imaging FMRI 58 LV dysfunction 58 hemodynamic variables 58 HOXB# 58 radiofrequency catheter ablation 58 hemodilution 58 monocytic 58 single photon emission 58 pairwise comparisons 58 color Doppler sonography 58 nasal endoscopy 58 radiographic examinations 58 glycosylated hemoglobin HbA1c 58 Cathepsin B 58 prognostic marker 58 electroretinography 58 Angiogram 58 hyperinsulinemic euglycemic clamp 58 extracapsular extension 58 coronary computed tomography 58 metaanalysis 58 pharmacodynamic PD 58 thyrotropin 58 DEXA scans 58 advanced adenomas 58 HRCT 58 tissue oxygenation 58 haematologic 58 somatic mutations 58 microcalcifications 58 transesophageal 58 cells overexpressing 58 histopathologic diagnosis 58 ultrasound elastography 58 Plain radiographs 58 prospective multicenter study 58 catheter angiography 58 venography 58 neuropathologic 58 transurethral resection 58 sonographic examination 58 histological examination 58 cranial irradiation 58 ligand induced 58 multivariable analyzes 58 sestamibi 58 GSTP1 58 PET myocardial perfusion 58 clinico pathological 58 glomerular filtration 58 fluorodeoxyglucose FDG 58 PTPN# 58 TOP2A 58 adjuvant radiotherapy 58 immunofluorescence 58 intravesical therapy 58 pharmacodynamic effects 58 microglial 58 malignant lesions 58 Brodmann Area 58 Insulin sensitivity 58 MGd 58 oncologic outcomes 58 urolithiasis 58 univariate analyzes 58 CT angiogram 58 binary logistic regression 58 DEXA dual 58 upper endoscopy 58 nonischemic 58 chi squared 58 bronchial epithelial cells 58 coronary angiogram 58 antiangiogenic therapy 58 Subgroup analyzes 58 parenchymal 58 plasma lipid 58 corneal topography 58 nondiagnostic 58 FDDNP 58 osteopenic 58 #m Tc 58 pelvic irradiation 58 thymoma 58 metabolizing enzyme 58 normal karyotype 58 pancreatic endocrine 58 myocardial infarct size 58 mutated K ras 58 Pearson correlation coefficients 58 posterior cingulate 58 susceptibility loci 58 -#.# ± [002] 58 papillary carcinoma 58 proteomes 58 Sjögren syndrome 58 plasma adiponectin 58 NMES 58 tissue biopsies 58 Logistic regression analysis 58 T2 lesions 58 K ras mutations 58 cystoscopic 58 sonographically 58 Kaplan Meier analysis 57 differentiate squamous 57 abdominal ultrasound 57 pulmonary metastasis 57 thyroid nodule 57 computed tomography CT angiography 57 PIB PET 57 SPECT imaging 57 COR Analyzer 57 breast carcinoma 57 attenuation correction 57 vitro experiments 57 urography 57 prospectively randomized 57 endoscopic retrograde 57 carotid artery thickness 57 magnetic resonance angiography 57 precursor lesions 57 mutational analysis 57 karyotyping 57 SAXS 57 HER2 amplification 57 reproducible measurements 57 murine models 57 perfusion MRI 57 lactate dehydrogenase LDH 57 lymphadenectomy 57 Gamma Imaging BSGI 57 BSGI MBI 57 experimentally induced 57 multivariate regression analysis 57 thymectomy 57 lipoxygenase 57 OPCAB 57 invasive angiography 57 PET CT scan 57 esophageal carcinoma 57 HOMA IR 57 intraventricular 57 TURBT 57 peritoneal carcinomatosis 57 lymphovascular invasion 57 MALDI TOF MS 57 endometrioid 57 pharmacologic stress 57 endoscopic resection 57 bronchoalveolar lavage BAL 57 micro calcifications 57 Lipoprotein 57 LVNC 57 EQ 5D 57 atypical hyperplasia 57 spectroscopic technique 57 total thyroidectomy 57 T2 weighted MRI 57 Coronary CTA 57 multidetector row 57 mechanistic studies 57 osteoid osteoma 57 carcinoembryonic antigen 57 PITX2 57 BRAF V#E mutation 57 rheumatoid factor 57 microRNA expression 57 imaging MRI 57 adrenocortical 57 electroencephalograms 57 Abdominal ultrasound 57 postoperative complication 57 x ray computed tomography 57 SPECT MPI 57 Sentinel lymph node 57 siRNA knockdown 57 pulmonary metastases 57 cardiac troponin 57 proteoglycan 57 myeloperoxidase 57 immunocytochemistry 57 dermoscopy 57 Cystatin C 57 echocardiographic parameters 57 Poisson regression 57 ELISpot 57 Papillary 57 Leydig cell 57 molecular subtypes 57 PSADT 57 microarray analysis 57 Synovial 57 stereotactic radiotherapy 57 massively parallel sequencing 57 fig. S4 57 obstructive coronary artery 57 hyperplastic 57 pharmacodynamic parameters 57 coronary angiography 57 soluble CD# ligand 57 pituitary adenomas 57 keratectomy 57 RT qPCR 57 truncal 57 SNP rs# [002] 57 Fas ligand 57 gross hematuria 57 airway hyperresponsiveness 57 coronary arteriography 57 colon rectal 57 Functional neuroimaging 57 etiologic 57 PCa 57 HGPIN 57 Transesophageal 57 Breast Specific 57 morphometric analysis 57 Histopathologic examination 57 positron emission topography 57 qRT PCR 57 positron emitting 57 ANOVA 57 voxel 57 NIHSS 57 observational cohort study 57 histopathological examination 57 CD# expression [001] 57 Randomized clinical trials 57 nonmetastatic 57 flurpiridaz F 57 percutaneous vertebroplasty 57 deoxy D 57 COL#A# 57 renal tumors 57 Vizilite 57 diffusion MRI 57 core needle biopsy 57 Tumor Response 57 covariate 57 LDL HDL 57 Echocardiographic 57 adenoidectomy 57 hepatic enzyme 57 undergoing coronary angiography 57 esophagogastric 57 magnetic resonance spectroscopy MRS 57 nephron sparing surgery 57 fluoroscopically guided 57 liver resection 57 angiography CTA 57 sleeve lobectomy 57 seminal vesicle invasion 57 MMSE score 57 stimulated insulin secretion 57 Angiographic 57 tumoral 57 IgA deficiency 57 serum concentrations 57 Ultrasound scans 57 cartilage lesions 57 multiplanar 57 Lp PLA 2 57 endobronchial 57 adrenal masses 57 retrospectively analyzed 57 T1a 57 ASCUS 57 p# activation 57 Prostate Px + 57 multivariable Cox 57 chemoresistant 57 invasive coronary angiography 57 SELDI TOF 57 gefitinib Iressa 57 balloon dilation 57 bone density measurements 57 metabolomic 57 mediastinal lymph nodes 57 heterozygotes 57 fluorescent microscope 57 mammographic 57 intravital 57 extracranial 57 aortic root replacement 57 apolipoproteins 57 pretargeting 57 posttreatment 57 Transurethral 57 bronchoalveolar 57 epithelial tumors 57 airway responsiveness 57 Linear regression 57 extensive metabolizers 57 posttransplant 57 stereotactic radiosurgery SRS 57 sonographic appearance 57 beta1 integrin 57 Ki# 57 multivariable logistic regression 57 Sagittal 57 Intraoperative 57 Phylogenetic analyzes 57 Figure 1C 57 hormone receptor status 57 electrophysiological recordings 57 acute aortic dissection 57 preoperative PSA 57 BRCA2 mutation carriers 57 TMPRSS2 ERG fusion 57 meta regression 57 cell lysate 57 STRIDE PD 57 Bonferroni correction 57 lymph node involvement 57 hypericin 57 pharmacokinetic parameters 57 pretest probability 57 molecular biomarkers 57 vimentin 57 Bonferroni 57 alanine aminotransferase ALT 57 neuropsychological assessment 57 radical cystectomy 57 Figure 2C 57 Enzastaurin 57 serum albumin 57 thymidine kinase 57 hippocampal cells 57 cortical activation 57 inotropic agents 57 GBA mutations 57 ESR1 57 schwannomas 57 computed tomography CT scan 57 Electromyography 57 multiplanar reconstruction 57 CT Angiography 57 neoplasm 57 differentially regulated 56 p tau 56 Estrogen Receptor 56 Microscopic examination 56 prognostic variables 56 MDCTA 56 carotid artery stenosis 56 susceptibility locus 56 dose proportionality 56 logistic regression 56 ultrasonographic examination 56 Endometrial 56 nerve conduction velocity 56 thiopurine 56 overnight polysomnography 56 colonoscopic 56 absorption spectra 56 isoenzyme 56 cCTA 56 submucosal 56 GRNCM1 56 left ventricular diastolic 56 sonographic evaluation 56 preferentially bind 56 ventilation perfusion 56 elevated transaminases 56 estimated GFR 56 bronchoalveolar lavage fluid 56 CORE OM 56 metabolic parameters 56 thymidine 56 oncogenic mutations 56 ultrastructure 56 intracardiac 56 hypermethylated 56 plasma pharmacokinetics 56 plasma lipids 56 mouse mammary 56 computed tomography scanning 56 prognostic markers 56 cytotoxicity assays 56 anthropometric measures 56 carotid bruit 56 debulking surgery 56 sagittal 56 logistic regression models 56 IPAH 56 cognitive affective 56 multicentric 56 radiosensitivity 56 multidetector computed tomography 56 T2DM 56 Ejection Fraction 56 gated SPECT 56 pharmacodynamic properties 56 N telopeptide 56 bioluminescent imaging 56 Coronary angiography 56 multivariable adjusted 56 S nitrosylation 56 progesterone receptor PR 56 CEACAM1 56 Inflammatory diseases 56 Gram stain 56 thoracoscopic lobectomy 56 MDRD 56 cytogenetic abnormalities 56 androgen suppression 56 agarose gel electrophoresis 56 ELISPOT 56 colonography 56 autoradiography 56 Multivariate analyzes 56 mTOR inhibitors 56 enzyme kinetics 56 Quantitation 56 PSA kinetics 56 interstitial fibrosis 56 neurocognitive function 56 VEGF expression 56 Multidetector CT 56 radioiodine therapy 56 pathologic correlation 56 node metastases 56 Pharmacokinetic studies 56 specific antigen PSA 56 Endothelial function 56 bisulfite sequencing 56 triiodothyronine 56 Symptom severity 56 cortical atrophy 56 pyridostigmine 56 magnetic resonance spectroscopic imaging 56 calorimetric 56 myocardial necrosis 56 radical prostatectomy RP 56 somatosensory evoked potentials 56 pCR 56 Flow cytometry 56 metabolomic profiling 56 fluorescein 56 pathologic fractures 56 primary aldosteronism 56 hip resurfacing arthroplasty 56 Radiographs 56 RNFL 56 X ray absorption spectroscopy 56 renal cysts 56 splenocytes 56 VATS lobectomy 56 hierarchical clustering 56 intraoperative complications 56 chromosome #p#.# 56 cerebral angiogram 56 pancreatic lung 56 cytoreductive nephrectomy 56 hematoxylin eosin original 56 HepG2 cells 56 MR arthrography 56 based morphometry 56 CagA 56 radioimmunotherapy RIT 56 transcriptional profiling 56 thyroid nodules 56 PCR assay 56 nonalcoholic steatohepatitis NASH 56 chromosome aberrations 56 immunochemical fecal occult 56 external beam radiotherapy 56 phylogenetic analyzes 56 rotational angiography 56 ERCC1 56 glaucomatous 56 Pharmacodynamic 56 intensity modulated 56 aromatase inhibitor therapy 56 Skin sterol 56 enhanced sonography 56 perfusion defects 56 chemosensitivity 56 ependymomas 56 coronary CT angiography 56 chronic thromboembolic pulmonary 56 Sentinel Lymph Node Biopsy 56 coronary artery stenosis 56 resected pancreatic cancer 56 DEXA 56 immunofluorescent 56 gastroduodenal 56 EDEMA3 trial 56 methylated DNA 56 myeloproliferative diseases 56 computerized tomography CT scan 56 dorsal root ganglion 56 histological 56 Prognostic factors 56 appendiceal 56 Endoscopic ultrasound 56 Sonography 56 cervical lymph nodes 56 ELISA enzyme 56 SLNB 56 ECLS 56 ovarian carcinoma 56 sonographic 56 Neuropsychiatric Inventory NPI 56 flow cytometric analysis 56 sinonasal 56 splenic 56 esophagogastroduodenoscopy 56 lung lesions 56 hyperalgesia 56 prognostic indicator 56 neuro endocrine 56 anterior temporal 56 pancreatic adenocarcinoma 56 Intra operative 56 Multivariable logistic regression 56 breast lesions 56 myocardial perfusion imaging 56 histological subtypes 56 operable breast cancer 56 atypia 56 prospective longitudinal 56 tenodesis 56 serum retinol 56 renal artery stenosis 56 preoperative MRI 56 Cyclin E 56 B7 H4 56 acetabular dysplasia 56 manometry 56 troponin T 56 VCUG 56 constitutively expressed 56 SUVmax 56 situ hybridization 56 metastatic neuroendocrine tumors 56 chemoprevention trials 56 cerebral microbleeds 56 PCR RFLP 56 FGFs 56 microarray experiments 56 fluorescently tagged 56 x ray diffraction 56 QEEG 56 tryptase 56 hypoperfusion 56 GH deficiency 56 kallikrein 56 liver metastasis 56 Prognostic Value 56 neuritic

Back to home page